NZ331219A - Antipathogenic peptides having a non-hemolytic selective cytolytic activity and compositions comprising them - Google Patents
Antipathogenic peptides having a non-hemolytic selective cytolytic activity and compositions comprising themInfo
- Publication number
- NZ331219A NZ331219A NZ331219A NZ33121997A NZ331219A NZ 331219 A NZ331219 A NZ 331219A NZ 331219 A NZ331219 A NZ 331219A NZ 33121997 A NZ33121997 A NZ 33121997A NZ 331219 A NZ331219 A NZ 331219A
- Authority
- NZ
- New Zealand
- Prior art keywords
- peptide
- hemolytic
- cytolytic activity
- cells
- cytolytic
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 8
- 230000001461 cytolytic effect Effects 0.000 title abstract 6
- 230000002949 hemolytic effect Effects 0.000 title abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 2
- 230000001775 anti-pathogenic effect Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 210000004027 cell Anatomy 0.000 abstract 3
- 210000003743 erythrocyte Anatomy 0.000 abstract 2
- 125000000539 amino acid group Chemical group 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000003211 malignant effect Effects 0.000 abstract 1
- 244000052769 pathogen Species 0.000 abstract 1
- 230000001717 pathogenic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/461—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from fish
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- C07K14/43563—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
- C07K14/43572—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects from bees
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Toxicology (AREA)
- Insects & Arthropods (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL11722396A IL117223A0 (en) | 1996-02-22 | 1996-02-22 | Antipathogenic polypeptides and compositions comprising them |
| PCT/IL1997/000066 WO1997031019A2 (en) | 1996-02-22 | 1997-02-20 | Antipathogenic peptides and compositions comprising them |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ331219A true NZ331219A (en) | 2000-04-28 |
Family
ID=11068576
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ331219A NZ331219A (en) | 1996-02-22 | 1997-02-20 | Antipathogenic peptides having a non-hemolytic selective cytolytic activity and compositions comprising them |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US6172038B1 (enExample) |
| EP (1) | EP0904291A2 (enExample) |
| JP (1) | JP2000506128A (enExample) |
| KR (2) | KR19990087100A (enExample) |
| CN (1) | CN1216549A (enExample) |
| AU (1) | AU730069B2 (enExample) |
| BR (1) | BR9707691A (enExample) |
| CA (1) | CA2247025A1 (enExample) |
| CZ (1) | CZ264398A3 (enExample) |
| EA (1) | EA199800754A1 (enExample) |
| IL (2) | IL117223A0 (enExample) |
| NZ (1) | NZ331219A (enExample) |
| WO (1) | WO1997031019A2 (enExample) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR9807456A (pt) * | 1997-02-20 | 2000-04-25 | Yeda Res & Dev | Peptìdios antipatogênicos sintéticos e composições que compreendem os mesmos |
| US6818213B1 (en) | 1998-07-13 | 2004-11-16 | Board Of Regents, The University Of Texas System | Cancer treatment compositions comprising therapeutic conjugates that bind to aminophospholipids |
| AU750414B2 (en) | 1998-07-13 | 2002-07-18 | Board Of Regents, The University Of Texas System | Cancer treatment methods using therapeutic conjugates that bind to aminophospholipids |
| US6660843B1 (en) | 1998-10-23 | 2003-12-09 | Amgen Inc. | Modified peptides as therapeutic agents |
| US7488590B2 (en) | 1998-10-23 | 2009-02-10 | Amgen Inc. | Modified peptides as therapeutic agents |
| HK1042114B (zh) | 1998-10-23 | 2006-09-29 | Amgen K-A, Inc. | 与mp1受体结合并具有血小板生成活性的模拟二聚体血小板生成素肽 |
| GB0005703D0 (en) | 2000-03-09 | 2000-05-03 | Alpharma As | Compounds |
| IL139720A0 (en) * | 2000-11-16 | 2002-02-10 | Yeda Res & Dev | Diastereomeric peptides and pharmaceutical compositions comprising them |
| CA2529125A1 (en) * | 2003-06-19 | 2004-12-23 | Yeda Research & Development Co. Ltd. | Antimicrobial and anticancer lipopeptides |
| CA2572765C (en) | 2004-07-08 | 2013-05-21 | Amgen Inc. | Compound having improved bioefficiency when administered in a multidose regimen |
| US7442778B2 (en) | 2004-09-24 | 2008-10-28 | Amgen Inc. | Modified Fc molecules |
| WO2006068768A2 (en) * | 2004-11-24 | 2006-06-29 | Hanna Skubatch | Methods and compositions for treating conditions |
| WO2006128289A1 (en) * | 2005-06-02 | 2006-12-07 | University Of Manitoba | Use of brevinin-2r in the treatment of cancer |
| US8008453B2 (en) | 2005-08-12 | 2011-08-30 | Amgen Inc. | Modified Fc molecules |
| WO2007074457A2 (en) * | 2005-12-27 | 2007-07-05 | Yeda Research And Development Co. Ltd. | Histidine-containing diastereomeric peptides and uses thereof |
| CA2637221A1 (en) | 2006-02-10 | 2007-08-16 | Dermagen Ab | Novel antimicrobial peptides and use thereof |
| US9283260B2 (en) | 2006-04-21 | 2016-03-15 | Amgen Inc. | Lyophilized therapeutic peptibody formulations |
| JP6205364B2 (ja) * | 2012-09-05 | 2017-09-27 | 株式会社メニコン | 薬物徐放性眼用レンズ及びその製造方法 |
| JP6093528B2 (ja) * | 2012-09-19 | 2017-03-08 | 株式会社ミルボン | スクリーニング方法 |
| US11103547B2 (en) | 2016-02-04 | 2021-08-31 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Methods for disrupting biofilms |
| GB2557654A (en) * | 2016-12-14 | 2018-06-27 | Uea Enterprises Ltd | Method for nucleic acid depletion |
| CN113528600A (zh) * | 2021-07-08 | 2021-10-22 | 石河子大学 | 一种利用沙门氏菌诱导蝇蛆制备抗菌肽的方法 |
| CN119607173A (zh) * | 2025-01-07 | 2025-03-14 | 天津医科大学朱宪彝纪念医院(天津医科大学代谢病医院、天津代谢病防治中心) | 小分子肽lklkll在制备降血糖产品中的应用 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5258454A (en) * | 1988-09-01 | 1993-11-02 | Riso National Laboratory | Peptide synthesis method and solid support for use in the method |
-
1996
- 1996-02-22 IL IL11722396A patent/IL117223A0/xx unknown
-
1997
- 1997-02-20 WO PCT/IL1997/000066 patent/WO1997031019A2/en not_active Ceased
- 1997-02-20 EA EA199800754A patent/EA199800754A1/ru unknown
- 1997-02-20 CZ CZ982643A patent/CZ264398A3/cs unknown
- 1997-02-20 JP JP9529954A patent/JP2000506128A/ja not_active Ceased
- 1997-02-20 AU AU17319/97A patent/AU730069B2/en not_active Ceased
- 1997-02-20 US US09/125,605 patent/US6172038B1/en not_active Expired - Fee Related
- 1997-02-20 NZ NZ331219A patent/NZ331219A/xx unknown
- 1997-02-20 BR BR9707691A patent/BR9707691A/pt unknown
- 1997-02-20 CN CN97194000A patent/CN1216549A/zh active Pending
- 1997-02-20 EP EP97904561A patent/EP0904291A2/en not_active Ceased
- 1997-02-20 IL IL12573497A patent/IL125734A/xx not_active IP Right Cessation
- 1997-02-20 CA CA002247025A patent/CA2247025A1/en not_active Abandoned
- 1997-02-20 KR KR1019980706488A patent/KR19990087100A/ko not_active Withdrawn
-
1998
- 1998-02-19 KR KR1019997007477A patent/KR20000071187A/ko not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| US6172038B1 (en) | 2001-01-09 |
| IL125734A (en) | 2005-08-31 |
| JP2000506128A (ja) | 2000-05-23 |
| IL125734A0 (en) | 1999-04-11 |
| AU1731997A (en) | 1997-09-10 |
| AU730069B2 (en) | 2001-02-22 |
| KR19990087100A (ko) | 1999-12-15 |
| EA199800754A1 (ru) | 1999-10-28 |
| IL117223A0 (en) | 1996-06-18 |
| CZ264398A3 (cs) | 1999-01-13 |
| WO1997031019A3 (en) | 1997-10-23 |
| WO1997031019A2 (en) | 1997-08-28 |
| BR9707691A (pt) | 1999-07-27 |
| EP0904291A2 (en) | 1999-03-31 |
| KR20000071187A (ko) | 2000-11-25 |
| CA2247025A1 (en) | 1997-08-28 |
| CN1216549A (zh) | 1999-05-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AUPP051497A0 (en) | Antimicrobial peptides | |
| DE69731373D1 (de) | Cc-chemokinzeptor c-c ckr-5, dessen derivate und verwendungen | |
| GR3031919T3 (en) | PEPTIDES OF HUMAN p53 PROTEIN FOR USE IN HUMAN T CELL RESPONSE INDUCING COMPOSITIONS, AND HUMAN p53 PROTEIN-SPECIFIC CYTOTOXIC T-LYMPHOCYTES. | |
| GR3029791T3 (en) | Improved immunogenic compositions against human gastrin 17 | |
| EP2016950A8 (en) | Pharmaceutical composition comprising an exendin-4 peptide | |
| WO1995007992A3 (en) | Cloned glutamic acid decarboxylase | |
| CA2395266A1 (en) | Use of acid-stable subtilisin proteases in animal feed | |
| IE802014L (en) | Peptides | |
| EA199900752A1 (ru) | Противопатогенные синтетические пептиды и композиции, их включающие | |
| EP1319023B8 (en) | An hsp70 peptide stimulating natural killer (nk) cell activity and uses thereof | |
| RU94041224A (ru) | Пептиды с органозащитной активностью, фармацевтическая композиция на их основе и их применение в терапии | |
| BG102362A (en) | New derivatives of amino acids, their preparation and application | |
| GR3024905T3 (en) | Bpc peptides, their preparation and use. | |
| CA2186423A1 (en) | Protein which induces interferon-gamma production by immunocompetent cell | |
| PL349490A1 (en) | Baby food stimulating growth of the thymus | |
| IL127907A0 (en) | Amino acid compositions and use thereof in immunosuppression | |
| MY104909A (en) | Peptide compounds. | |
| FR2446292B1 (enExample) | ||
| MY113407A (en) | Tri-, tetra-, penta-, and polypeptides and their therapeutic use as an antidepressant agent | |
| IL132310A0 (en) | Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation | |
| WO1998017626A3 (en) | Positively charged non-natural amino acids, methods of making thereof, and use thereof in peptides | |
| AU5168099A (en) | Use of novel agents inducing cell death in synergy with interferons | |
| IL139604A (en) | Fibrinogen-beta chain derived peptide, compositions comprising same and use thereof | |
| EP0264953A3 (en) | Amino acid preparations containing n,n'-bis-l-amino acid-l-cystin peptides for oral and parenteral use | |
| GB1294771A (en) | Thyrocalcitonin derivative |